17β-estradiol (E2) can induce tumor cell growth by promoting the activation of the high mobility group box 1 protein (HMGB1)/Cav-1 pathway, enhancing autophagy and inhibiting apoptosis in BT474 human breast cancer cells. This evidence concerns the gene CAV1 and breast carcinoma.